Return to search

The Economic Burden of Gluten-Free Products and the Potential of Dietary Inhibitors of Transglutaminase-2

Celiac disease (CD) is a chronic immune-mediated disease of the small intestine caused by the ingestion of gluten. Gluten presents to the intestine largely intact where it is deamidated by Transglutaminase-2 (TG2), increasing affinity for Human Leukocyte Antigen DQ2 (HLA-DQ2) and forming a complex that elicits an inflammatory response ultimately leading to villous atrophy. The only current treatment is strict adherence to a gluten-free diet, though TG2 inhibition is an attractive therapy due its central role in CD pathogenesis. Cocoa contains procyanidin-B2, theobromine and caffeine and may be capable of inhibiting TG2-induced intestinal inflammation and reduce CD symptoms. Procyanidin-B2 rich cocoa extracts reduced TG2 levels by up to 77% in vitro using Caco-2 cells. Significant TG2 inhibition was seen when cocoa extracts contained at least 8.5 μM procyanidin-B2 (p<0.05). Other CD inflammatory biomarkers including COX-2 and IL-15 were also significantly decreased in the presence of cocoa extracts. Serum cytokines IL-6, IL-8 and IL-1β are commonly used to monitor CD and were analyzed using ELISA to confirm the inhibition of inflammatory biomarkers. This study shows promising results for use of a bioactive-rich cocoa product as a dietary inhibitor of TG2 that can be used with wheat-based products as an alternative therapy in CD.

Identiferoai:union.ndltd.org:LSU/oai:etd.lsu.edu:etd-04042016-152133
Date18 April 2016
CreatorsKramer, Kristen
ContributorsLosso, Jack, King, Joan, Xu, Zhimin
PublisherLSU
Source SetsLouisiana State University
LanguageEnglish
Detected LanguageEnglish
Typetext
Formatapplication/pdf
Sourcehttp://etd.lsu.edu/docs/available/etd-04042016-152133/
Rightsunrestricted, I hereby certify that, if appropriate, I have obtained and attached herein a written permission statement from the owner(s) of each third party copyrighted matter to be included in my thesis, dissertation, or project report, allowing distribution as specified below. I certify that the version I submitted is the same as that approved by my advisory committee. I hereby grant to LSU or its agents the non-exclusive license to archive and make accessible, under the conditions specified below and in appropriate University policies, my thesis, dissertation, or project report in whole or in part in all forms of media, now or hereafter known. I retain all other ownership rights to the copyright of the thesis, dissertation or project report. I also retain the right to use in future works (such as articles or books) all or part of this thesis, dissertation, or project report.

Page generated in 0.002 seconds